FDA approved KEYTRUDA in combination with chemotherapy for adult patients with endometrial carcinoma Read more
U.S. FDA approves CAPVAXIVE (V116), specifically designed for pneumococcal disease in adults Read more
Pharma industry focuses on strategic investments amid reduced deal activity by 26.1 % compared to May 2023: GlobalData Read more
AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData Read more